Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to assess the neuro-endocrine response to hypoglycaemia in PHH vs. non-PHH post-gastric bypass individuals.


Clinical Trial Description

Obesity is a major global public health concern, for which the most effective therapy is bariatric surgery. Beyond weight loss, bariatric surgery exerts powerful effects on glucose metabolism, achieving complete type 2 diabetes remission in up to 70% of cases. An exaggeration of these effects, however, can result in an increasingly recognized metabolic complication known as postprandial hyperinsulinaemic hypoglycaemia (PHH). The condition manifests 1-3 years after surgery with hypoglycaemic episodes after meals. Emerging data suggest that PHH is more frequent than previously thought and affects approximately 30% of postoperative patients, more commonly after gastric bypass than sleeve gastrectomy . Despite such frequency, the underlying pathophysiology of PHH remains incompletely understood. A striking finding in PHH patients is the observed lack of insulin suppression and inadequate glucagon response to the sharply falling glucose levels. The blunted glucagon response to hypoglycaemia may result from altered alpha-cell function (acute or chronic) and an interaction with gut hormones (e.g. glucagon-like peptide 1 (GLP-1) that is known to exert glucagon-inhibitory effects) or altered brain signalling. It is conceivable that, both, lack of endogenous insulin suppression in response to falling postprandial blood glucose levels and impaired glucagon secretion contribute to PHH. Further neuroendocrine regulatory processes to counteract hypoglycaemia involve catecholamines, cortisol, growth hormone and autonomic nervous system activity. Two previous studies examined counter-regulatory hormones during experimentally induced hypoglycaemia in patients after gastric bypass surgery and found lower levels than before surgery, suggesting that bariatric surgery per se influences counter-regulation to hypoglycaemia. Underlying mechanisms remain speculative. Of note, impaired neuroendocrine counter-regulation to hypoglycaemia is further supported by the high proportion of asymptomatic patients, which may be reflective of impaired hypoglycaemia awareness. The role of counter-regulatory hormones in PHH patients remains not fully understood. Apart from the neuroendocrine milieu, effectiveness of hypoglycaemia counter-regulation depends on the capacity to provide glucose from the liver, also known as endogenous glucose production. In healthy humans, approximately 85% of the glucose produced by the liver during the initial 60-90min of hypoglycaemia is derived from liver glycogen. Postprandial hepatic glycogen stores, in turn, depend heavily on the hepatic glucose uptake following a meal. Postprandial hepatic glucose disposal and mobilization of hepatic glucose during hypoglycaemia in PHH patients remain unexplored to date. There is currently no evidence, that increased insulin sensitivity is implicated in the pathophysiology of PHH. Conversely, previous studies suggested increased non-insulin dependent whole body glucose uptake in PHH compared to non-PHH in the light of similar or even decreased insulin sensitivity. The primary objective of this study is to assess the neuro-endocrine response to hypoglycaemia in PHH vs. non-PHH post-gastric bypass individuals. The investigators hypothesize that the glucagon response to standardized and controlled hypoglycaemia is significantly diminished in PHH vs. non-PHH post-gastric bypass individuals. Involvement of non-surgical non-PHH controls and sleeve-gastrectomy non-PHH controls will allow to explore effects of bariatric surgery on counter-regulatory mechanisms to hypoglycaemia, including differences between procedures (gastric bypass vs. sleeve gastrectomy). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04334161
Study type Observational
Source University Hospital Inselspital, Berne
Contact
Status Completed
Phase
Start date October 2, 2020
Completion date July 13, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04422236 - A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
Withdrawn NCT04543526 - A Post-market Observational Study With the easyEndoTM Universal Linear Cutting Stapler in Standard Laparoscopic and Robot-assisted Laparoscopic Roux-en-Y Gastric Bypass (RYGB) Surgery
Completed NCT01867255 - Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels Phase 1
Completed NCT03440138 - Defining Benchmarks in Bariatric Surgery
Completed NCT04972357 - Bariatric Procedures and Changes Gastric Passage
Active, not recruiting NCT03049696 - Does Participation in a Pre-Operative Physical Activity Program Improve Patient Outcomes and Quality of Life? N/A
Completed NCT02128581 - A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake Phase 1
Completed NCT03478098 - Meal Glycaemic Index and Exercise After Gastric Bypass N/A
Recruiting NCT04808206 - A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
Completed NCT04600596 - Photographic Food Recognition and Meal Size Estimation Before and After Roux-en-Y Gastric Bypass
Completed NCT04330196 - Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. N/A
Completed NCT03968757 - Assessing the Safety and Performance of the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Gastric Bypass Surgery
Active, not recruiting NCT02068001 - Changes in Food Preference and Food Cue Responsivity After Bariatric Surgery N/A
Completed NCT02204813 - To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery Phase 1
Recruiting NCT04324515 - Randomized Trial Comparing Gastric Bypass With and Without Cholecystectomy N/A
Active, not recruiting NCT05560789 - The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia N/A
Not yet recruiting NCT04172116 - Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass
Completed NCT04609449 - A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass N/A
Recruiting NCT05216926 - Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 3 N/A
Completed NCT05212207 - Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 1